Fusion Antibodies strengthens platform with patent approval in Japan
(Alliance News) - Fusion Antibodies PLC on Monday said Japan's patent office has formally granted approval to its patent application covering two families of antibodies. Read More
| Price | 13.75p on 20-05-2026 at 16:30:01 |
|---|---|
| Change | -0.50p -3.51% |
| Buy | 14.00p |
| Sell | 13.50p |
| Last Trade: | Sell 45,793.00 at 13.555p |
| Day's Volume: | 304,124 |
| Last Close: | 13.75p |
| Open: | 14.25p |
| ISIN: | GB00BDQZGK16 |
| Day's Range | 13.75p - 14.25p |
| 52wk Range: | 5.90p - 20.50p |
| Market Capitalisation: | £17.19m |
| VWAP: | 13.77197p |
| Shares in Issue: | 125.02m |
Sector: Health Care and Related Services
Listed In: FTSE AIM All-Share,
Fusion Antibodies (FAB) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 45,793 | 13.555p | Ordinary |
16:10:54 - 20-May-26 |
| Sell* | 20,000 | 13.555p | Ordinary |
16:10:46 - 20-May-26 |
| Sell* | 10,000 | 13.60p | Ordinary |
15:57:08 - 20-May-26 |
| Sell* | 20,000 | 13.65p | Ordinary |
15:55:28 - 20-May-26 |
| Sell* | 20,000 | 13.65p | Ordinary |
15:40:35 - 20-May-26 |
| Sell* | 369 | 13.555p | Ordinary |
15:36:42 - 20-May-26 |
| Sell* | 43,170 | 13.91p | Ordinary |
15:34:20 - 20-May-26 |
| Sell* | 296 | 13.555p | Ordinary |
15:32:03 - 20-May-26 |
| Buy* | 6 | 15.00p | SI Trade |
14:57:45 - 20-May-26 |
| Buy* | 12 | 15.00p | SI Trade |
14:57:45 - 20-May-26 |
Fusion Antibodies (FAB) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 11th May 2026 3:06 pm | RNS | Holding(s) in Company |
| 11th May 2026 11:05 am | RNS | Grant of patent in Japan |
| 5th May 2026 7:00 am | RNS | Year-end trading statement |
| 30th Mar 2026 7:00 am | RNS | Antibody IP transfer agreement |
| 17th Feb 2026 11:42 am | RNS | Director/PDMR Shareholding |
| 4th Feb 2026 3:27 pm | RNS | Holding(s) in Company |
| 2nd Feb 2026 11:33 am | RNS | Holding(s) in Company |
| 30th Jan 2026 5:00 pm | RNS | Total Voting Rights |
| 27th Jan 2026 7:05 am | RNS | Issue of Director Shares |
| 27th Jan 2026 7:00 am | RNS | Placing and Subscription to raise approx £1.4m |